A novel human iPSC-derived heart tissue model replicates HFpEF diastolic dysfunction and reveals how SGLT2 inhibitors reduce cardiac inflammation through endothelial pathways.
Most Recent Articles
Phase 1a Trial Demonstrates Sustained Lipid Reduction via CTX310 Gene Editing
A Phase 1a trial shows that a single infusion of CRISPR-Cas9 therapy CTX310 achieves 12-month reductions in LDL cholesterol and triglycerides without serious adverse events.
Neurological and Systemic Complications of Varicella Zoster Virus Reactivation: A Comprehensive Review
A Nature Reviews Disease Primers study highlights that latent varicella zoster virus reactivation can drive severe stroke and neurovascular disease without causing a shingles rash.
Targeting EFHD1 Calcium-Dependent Organellar Contact Stabilization to Prevent Hepatic Injury
Inhibiting the EFHD1 protein reduces liver inflammation and scarring by up to 60% by blocking a maladaptive antiviral stress response in MASH.
Gut-Liver Axis Metabolomics Link Microbial Imidazole Propionate to Reduced Survival in PSC
A Nature Metabolism study reveals that gut bacterial imidazole propionate drives primary sclerosing cholangitis via mTORC1 signaling, opening new therapeutic avenues.